Evidence map›Paper›PMID 25849983›Full record

ArticleTranslational psychiatry2015

D-cycloserine to enhance extinction of cue-elicited craving for alcohol: a translational approach.

J MacKillop, L R Few, M K Stojek, C M Murphy, S F Malutinok, F T Johnson, S G Hofmann, J E McGeary, R M Swift, P M Monti

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. New Approaches to Addiction Treatment Based on Learning and Memory.Current topics in behavioral neurosciences · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Hazardous drinking and alcohol use disorders.Nature reviews. Disease primers · 2022
    Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Medications for alcohol use disorders: An overview.Pharmacology & therapeutics · 2018
    Review
  18. Article
  19. Prefrontal Cortex KThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

J MacKillop1] Peter Boris Centre for Addictions Research, Department of Psychiatry and Behavioural Neurosciences, McMaster University/St. Joseph's Healthcare Hamilton, Hamilton, ON, Canada [2] Homewood Research Institute, Homewood Health Centre, Guelph, ON, Canada [3] Center for Alcohol and Addiction Studies, Brown University, Providence, RI, USA.ORCID 0000000341189500
L R FewDepartment of Psychiatry, Washington University, St. Louis, MO, USA.
M K StojekDepartment of Psychology, University of Georgia, Athens, GA, USA.
C M MurphyDepartment of Psychology, University of Georgia, Athens, GA, USA.
S F MalutinokDepartment of Psychology, University of Georgia, Athens, GA, USA.
F T JohnsonDepartment of Psychology, University of Georgia, Athens, GA, USA.
S G HofmannDepartment of Psychological and Brain Sciences, Boston University, Boston, MA, USA.
J E McGeary1] Providence Veterans Affairs Medical Center, Providence, RI, USA [2] Division of Behavioral Genetics, Department of Psychiatry, Rhode Island Hospital, Providence, RI, USA [3] Center for Alcohol and Addiction Studies, Brown University, Providence, RI, USA.
R M Swift1] Center for Alcohol and Addiction Studies, Brown University, Providence, RI, USA [2] Department of Psychological and Brain Sciences, Boston University, Boston, MA, USA.
P M MontiCenter for Alcohol and Addiction Studies, Brown University, Providence, RI, USA.
University of Georgia · USBrown University · USBoston University · USSt. Joseph’s Healthcare Hamilton · CAWashington University in St. Louis · US

Funding

RESEARCH TRAINING IN CONNECTIVE TISSUE DISEASEST32AR007317 · NIAMS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI POSTLETHWAITE, ARNOLD E · 1986 to 2008
$1.1M
Enhancing Alcoholism Pharmacotherapy Research via Behavioral EconomicsK23AA016936 · NIAAA · UNIVERSITY OF GEORGIA · PI MACKILLOP, JAMES · 2008 to 2012
$805k
D-Cyloserine to Enhance Extinction to Alcohol CuesR21AA017696 · NIAAA · UNIVERSITY OF GEORGIA · PI MACKILLOP, JAMES · 2009 to 2010
$416k
NIAAA NIH HHS K23 AA016936NIAAA NIH HHS R21 AA017696NIAAA NIH HHS R21 AA017696-01A1NIAMS NIH HHS T32 AR007317NIDA NIH HHS T32 DA007317
6 · The paper itself

Abstract

Cue-elicited craving for alcohol is well established but extinction-based treatment to extinguish this response has generated only modest positive outcomes in clinical trials. Basic and clinical research suggests that D-cycloserine (DCS) enhances extinction to fear cues under certain conditions. However, it remains unclear whether DCS would also accelerate extinction of cue-elicited craving for alcohol. The goal of the current study was to examine whether, compared with placebo (PBO), DCS enhanced extinction of cue-elicited craving among treatment-seeking individuals with alcohol use disorders (AUDs). Participants were administered DCS (50 mg) or PBO 1 h before an alcohol extinction paradigm in a simulated bar environment on two occasions. The extinction procedures occurred 1 week apart and were fully integrated into outpatient treatment. Subjective craving for alcohol was the primary variable of interest. Follow-up cue reactivity sessions were conducted 1 week and 3 weeks later to ascertain persisting DCS effects. Drinking outcomes and tolerability were also examined. DCS was associated with augmented reductions in alcohol craving to alcohol cues during the first extinction session and these effects persisted through all subsequent sessions, suggesting facilitation of extinction. Participants in the DCS condition reported significant short-term reductions in drinking, although these did not persist to follow-up, and found the medication highly tolerable. These findings provide evidence that DCS enhances extinction of cue-elicited craving for alcohol in individuals with AUDs in the context of outpatient treatment. The potential clinical utility of DCS is discussed, including methodological considerations and context-dependent learning.

Indexed as

CuesTranslational Research, BiomedicalAdultAgedAlcohol-Related DisordersAntimetabolitesCravingCycloserineExtinction, PsychologicalFemaleFollow-Up StudiesHumansMaleMiddle AgedOutpatientsTime FactorsAntimetabolitesCycloserine

Identifiers

PMID25849983
PMCPMC4462604
OpenAlexW2027053513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.